Nicox S.A. (OTCMKTS:NICXF – Get Free Report)’s share price dropped 36.4% on Friday . The company traded as low as $0.28 and last traded at $0.28. Approximately 4,500 shares were traded during mid-day trading, The stock had previously closed at $0.44.
Nicox Stock Down 36.4 %
The company has a fifty day moving average of $0.24 and a 200-day moving average of $0.33.
About Nicox
Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.
Recommended Stories
- Five stocks we like better than Nicox
- Why is the Ex-Dividend Date Significant to Investors?
- Realty Income: An Anchor in Volatile Markets
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Are Penny Stocks a Good Fit for Your Portfolio?
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
Receive News & Ratings for Nicox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nicox and related companies with MarketBeat.com's FREE daily email newsletter.
